MBX Biosciences Files 4/A Amendment
Ticker: MBX · Form: 4/A · Filed: Apr 22, 2026 · CIK: 0001776111
| Field | Detail |
|---|---|
| Company | Mbx Biosciences, Inc. (MBX) |
| Form Type | 4/A |
| Filed Date | Apr 22, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: insider-filing, amendment, ownership
Related Tickers: DCPH
TL;DR
MBX Biosciences filed a 4/A amendment on 4/22/26 for ownership changes on 11/6/25.
AI Summary
This 4/A filing amends a previous statement of changes in beneficial ownership for MBX Biosciences, Inc. The amendment was filed on April 22, 2026, and pertains to events on November 6, 2025. The filing is related to Deciphera Pharmaceuticals, Inc., with Steven L. Hoerter listed as a reporting individual.
Why It Matters
This filing is an amendment to a statement of changes in beneficial ownership, indicating a correction or addition to previously reported information regarding securities ownership.
Risk Assessment
Risk Level: low — A 4/A filing is an amendment to a previous filing and does not typically introduce new material risks.
Key Numbers
- 2026-04-22 — Filing Date (Date the amendment was accepted)
- 2025-11-06 — Period of Report (Date to which the ownership changes relate)
Key Players & Entities
- MBX Biosciences, Inc. (company) — Issuer
- Deciphera Pharmaceuticals, Inc. (company) — Mailing Address Company
- Steven L. Hoerter (person) — Reporting Individual
- 0001776111 (company) — MBX Biosciences CIK
- 0001533451 (company) — Deciphera Pharmaceuticals CIK
FAQ
What specific information is being amended in this 4/A filing?
The filing is a 4/A, which is an amendment to a previous statement of changes in beneficial ownership. The specific details of the amendment are not provided in the document header.
Who is the reporting individual associated with this filing?
Steven L. Hoerter is listed as the reporting individual.
What is the CIK for MBX Biosciences, Inc.?
The CIK for MBX Biosciences, Inc. is 0001776111.
What is the relationship between MBX Biosciences, Inc. and Deciphera Pharmaceuticals, Inc. based on this filing?
Deciphera Pharmaceuticals, Inc. is listed as the company associated with the mailing address for the filing.
What is the period of report for the ownership changes being amended?
The period of report for the ownership changes is November 6, 2025.
Filing Details
This Form 4/A (Form 4/A) was filed with the SEC on April 22, 2026 by Steven L. Hoerter regarding MBX Biosciences, Inc. (MBX).